Search

Search Constraints

You searched for: Author/Creator Segedin, B.

Search Results

1. OC-0025 Tumor regression of cervical cancer during chemoradiation evaluated by the T-score in EMBRACE I. (May 2021)

2. OC-0051: Fatigue, insomnia, hot flashes (CTCAE) after definitive RCHT+IGABT for cervical cancer (EMBRACE). (May 2017)

3. OC-0052: Physician assessed and patient reported bladder morbidity after RCHT and IGABT for cervical cancer. (May 2017)

4. OC-0053: Physician assessed and patient reported limb edema after RCHT + IGABT for cervical cancer (EMBRACE). (May 2017)

6. OC-0056: Bowel morbidity in cervix cancer after RCHT+IGABT; physician and patient reported outcome - EMBRACE. (May 2017)

7. OC-0059 Clinical characteristics and risk factors for local failure in cervix cancer patients after MR IGABT. (May 2021)

8. OC-0072: Risk factors for ureteral stricture after IGABT in cervical cancer: results from the EMBRACE studies. (April 2018)

9. OC-0105: Combined IC/IS BT does not increase late morbidity compared with IC BT in IGABT for locally advanced cervical cancer. (April 2015)

10. OC-0296 Risk factors for severe gastrointestinal morbidity in locally advanced cervix cancer (EMBRACE study). (August 2021)